These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18287588)

  • 1. Effect of selective serotonin reuptake inhibitors on cardiovascular morbidity and mortality.
    Von Ruden AE; Adson DE; Kotlyar M
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):32-40. PubMed ID: 18287588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which SSRI is safest for patients with CVD and major depressive disorder?
    Dunham S; Wilkening GL; Schwier NC
    JAAPA; 2021 Apr; 34(4):18-19. PubMed ID: 33735134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.
    Ruhé HG; Huyser J; Swinkels JA; Schene AH
    J Clin Psychiatry; 2006 Dec; 67(12):1836-55. PubMed ID: 17194261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors.
    van Melle JP; de Jonge P; van den Berg MP; Pot HJ; van Veldhuisen DJ
    Drugs; 2006; 66(16):2095-107. PubMed ID: 17112303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials.
    Barth M; Kriston L; Klostermann S; Barbui C; Cipriani A; Linde K
    Br J Psychiatry; 2016 Feb; 208(2):114-9. PubMed ID: 26834168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?
    Hamid H; Kanner AM
    Epilepsy Behav; 2013 Mar; 26(3):261-5. PubMed ID: 23395350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
    Foley P; Lawler A; Chandran S; Mead G
    J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):709-10. PubMed ID: 24403283
    [No Abstract]   [Full Text] [Related]  

  • 12. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
    Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
    CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder.
    Varigonda AL; Jakubovski E; Taylor MJ; Freemantle N; Coughlin C; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2015 Jul; 54(7):557-64. PubMed ID: 26088660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
    Papakostas GI; Homberger CH; Fava M
    J Psychopharmacol; 2008 Nov; 22(8):843-8. PubMed ID: 18308801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vortioxetine: a New Treatment for Major Depressive Disorder.
    Connolly KR; Thase ME
    Expert Opin Pharmacother; 2016; 17(3):421-31. PubMed ID: 26679430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.
    Eyding D; Lelgemann M; Grouven U; Härter M; Kromp M; Kaiser T; Kerekes MF; Gerken M; Wieseler B
    BMJ; 2010 Oct; 341():c4737. PubMed ID: 20940209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E; Cavenett S; McArthur A; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting serotonin reuptake inhibitors and the therapeutic potential of "uptake-2" in psychiatric disorders.
    Daws LC; Koek W; Mitchell NC
    ACS Chem Neurosci; 2013 Jan; 4(1):16-21. PubMed ID: 23336039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder.
    Papakostas GI; Fava M
    Eur Neuropsychopharmacol; 2007 Jan; 17(1):32-6. PubMed ID: 16762534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.